Multidisciplinary Engagement Increases Medications in-Hand for Patients Hospitalized With Asthma

Kavita Parikh1, Karen Perry2, Candice Pantor2

  • 1Children's National Hospital and the George Washington School of Medicine, Washington, District of Columbia kparikh@childrensnational.org.

Pediatrics
|November 23, 2019
PubMed

Insights

Hospitalized children with asthma are now more likely to receive their discharge medications thanks to a new process. This improvement in medication possession at discharge aims to reduce future asthma exacerbations.

Area of Science:

  • Pediatric Healthcare
  • Respiratory Medicine
  • Quality Improvement Science

Background:

  • Asthma exacerbations in children are a significant cause of school absenteeism and healthcare utilization.
  • A critical gap exists in ensuring children receive discharge prescriptions, increasing their risk for recurrent exacerbations.

Purpose of the Study:

  • To enhance medication possession at discharge for pediatric asthma patients.
  • To improve the transition of care for children hospitalized with asthma.

Main Methods:

  • A multidisciplinary team implemented a quality improvement initiative using the model for improvement.
  • Key strategies included process mapping, driver diagram development, and daily discharge huddles.
  • Statistical process control charts monitored the proportion of patients receiving medications in-hand at discharge.

Main Results:

  • Medication possession at discharge increased from 15% to over 80% for all eligible children.
  • For children with public insurance, possession rates exceeded 90%.
  • Length of stay and forgotten discharge medications remained stable.

Conclusions:

  • Multidisciplinary collaboration is crucial for improving medication possession at discharge for pediatric asthma patients.
  • Standardizing discharge processes can significantly enhance care transitions and potentially reduce readmissions.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.7K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
657
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
679
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.5K